Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
  • IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
  • Hospital Beata Maria Ana Madrid, Spain
  • Hospital Fundación Jiménez Diaz Madrid, Spain
View Trial Details
Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

NCT06215118

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center Coral Gables, Florida, United States
  • University of Miami Hospital and Clinics Deerfield Beach Deerfield Beach, Florida, United States
  • Sylvester Comprehensive Cancer Center- Doral Doral, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 43 locations
View Trial Details
Recruiting

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

NCT06459024

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Disease Attributes, +10 more
Locations
  • University Hospital Aachen Aachen, Germany
  • University Hospital Greifswald Greifswald, Germany
  • University Hospital Halle Halle, Germany
  • University Hospital of Rostock Rostock, Germany
View all 38 locations
View Trial Details
Recruiting

NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer

NCT05704829

Conditions
Disease Attributes, HER2-positive Early Breast Cancer, Pathologic Processes, +2 more
Locations
  • Klinikum Mittelbaden, Brustzentrum Baden-Baden, Baden-Wurttemberg, Germany
  • Praxis für Interdisziplinäre Onkologie und Hämatologie (PIO) Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
View all 44 locations
View Trial Details
Recruiting

Phase 2/3 Study of KPL-387 in Recurrent Pericarditis

NCT07010159

Conditions
Cardiovascular Diseases, Disease Attributes, Heart Diseases, +6 more
Locations
  • Investigational Site 018 Gilbert, Arizona, United States
  • Investigational Site 053 Phoenix, Arizona, United States
  • Investigational Site 030 Los Angeles, California, United States
  • Investigational Site 008 San Francisco, California, United States
View all 58 locations
View Trial Details

Related conditions